Erratum to: Switching to bictegravir/emtricitabine/tenofovir alafenamide maintained HIV-1 RNA suppression in participants with archived antiretroviral resistance including M184V/I.
Autor: | Andreatta K, Willkom M, Martin R, Chang S, Wei L, Liu H, Liu YP, Graham H, Quirk E, Martin H, White KL |
---|---|
Jazyk: | angličtina |
Zdroj: | The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Dec 01; Vol. 74 (12), pp. 3646-3647. |
DOI: | 10.1093/jac/dkz412 |
Databáze: | MEDLINE |
Externí odkaz: |